OPK 8-K 2026-10-02
OPKO HEALTH, INC. (OPK) 8-K dated 2026-10-02 — accession 0001193125-26-412284.
OPKO HEALTH, INC. (OPK) is a diagnostics & research company listed on US.
OPKO HEALTH, INC. filed a 8-K on 2026-10-02. Accession 0001193125-26-412284.
This 8-K covers: Other events (Item 8.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported OPK revenue for 2025-12-31 was $606.9M. Net income was -$225.7M. Revenue was down 14.9% from 2024-12-31 to 2025-12-31. OPK currently screens at market cap $1.07B.
Not investment advice. The OPK SEC hub lists recent forms. The stock page is the research view.